Loading...
UNCY UNICYCIVE THERAPEUTICS INC US FDA Inspections 8-K Filing
Back
NCYC
NCY
UNICYCIVE THERAPEUTICS INC
(UNCY)
Follow
FY2023 8 K
View More
Back
NCYC
NCY
UNICYCIVE THERAPEUTICS INC
(UNCY)
Follow
FY2023 8 K
Filing:
8 K
Published on:
23 Oct '23
Capital Structure Update
14 Apr '25
Financial Results
31 Mar '25
Nasdaq Compliance Notice
7 Jan '25
Financial Results
13 Nov '24
Nasdaq Compliance
24 Sep '24
Financial Results
14 Aug '24
Delisting
15 Jul '24
Delisting
15 Jul '24
Agreement with Shilpa Medic...
2 Jul '24
Stock Increase
26 Jun '24
Clinical Trial Results
25 Jun '24
Annual Meeting of Stockholders
20 Jun '24
Financial Results Announcement
13 May '24
Financial Results Announcement
28 Mar '24
Private Placement
14 Mar '24
Exchange Agreement and Cert...
14 Mar '24
Compliance Notice from Nasdaq
21 Feb '24
Earnings Reports
14 Nov '23
FDA Alignment on Oxylanthan...
23 Oct '23
Delisting
25 Sep '23
Change in Accounting Firm
31 Aug '23
Earnings Reports
14 Aug '23
Resignation of Auditor
31 Jul '23
Compliance Regained
26 Jul '23
Update on New Drug Application
29 Jun '23
Annual Meeting of Stockholders
26 Jun '23
Delisting
23 May '23
Financial Results Announcement
16 May '23
Amendment to Securities Pur...
10 Apr '23
Financial Results Announcement
31 Mar '23
Compliance with Nasdaq List...
30 Mar '23
Securities Purchase Agreement
6 Mar '23
Compliance Notice from Nasdaq
2 Mar '23
Delisting
7 Feb '23
License Agreement with Lotu...
2 Feb '23
External Links:
SEC
AI Assistant
Close
UNICYCIVE THERAPEUTICS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.